Samuel N. Hazen - Feb 17, 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Signature
/s/ Natalie Harrison Cline, Attorney-in-Fact
Stock symbol
HCA
Transactions as of
Feb 17, 2023
Transactions value $
-$9,664,627
Form type
4
Date filed
2/22/2023, 07:05 PM
Previous filing
Feb 7, 2023
Next filing
May 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Award $0 +94.9K +89.78% $0.00 201K Feb 17, 2023 Direct F1
transaction HCA Common Stock Tax liability -$9.66M -36.8K -18.33% $262.84 164K Feb 17, 2023 Direct
holding HCA Common Stock 813K Feb 17, 2023 By LP
holding HCA Common Stock 300K Feb 17, 2023 By 2022 GRAT
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 29, 2020, the reporting person was granted 47,440 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted.